Ad verification company Integral Ad Science (NASDAQ:IAS) in Q4 CY2024, with sales up 14% year on year to $153 million. Guidance for next quarter’s revenue was better than expected at $129.5 million at ...
Digital ad verification company Integral Ad Science (NASDAQ:IAS) reported Q3 CY2025 results , with sales up 15.6% year on year to $154.4 million. Its GAAP profit of $0.04 per share was 42.2% below ...
Revenue for Q4 2024 grew 14% to $153 million, with an adjusted EBITDA margin of 40%. Full-year 2024 revenue reached $530.1 million, marking a 12% increase with a 36% adjusted EBITDA margin. CEO Lisa ...
In the last three months, 4 analysts have published ratings on Integral Ad Science Holdi (NASDAQ:IAS), offering a diverse range of perspectives from bullish to bearish. The following table summarizes ...
Certification Demonstrates IAS's Commitment to the Highest Standards of Governance and Responsible Business Practices NEW YORK, Dec. 16, 2024 /PRNewswire/ -- Integral Ad Science (IAS), a leading ...
In the latest quarter, 4 analysts provided ratings for Integral Ad Science Holdi (NASDAQ:IAS), showcasing a mix of bullish and bearish perspectives. The table below offers a condensed view of their ...
A few months after SK Life Science began rolling out a road trip-themed TV commercial for its antiseizure medication Xcopri, the FDA is attempting to put the brakes on the ad. The regulator late last ...
Novacap has agreed to acquire Integral Ad Science Holding Corp. in a deal that values the advertising analytics company at about $1.9 billion. The Canadian buyout firm will pay $10.30 a share in cash ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback